Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Our innovative AI engine is revolutionizing the drug discovery process, enabling the creation of superior medications at an accelerated pace. The breakthroughs we achieve contribute to the development of medicines more efficiently and effectively. Our portfolio of AI-driven discoveries encompasses entirely owned and collaboratively developed pipeline assets, supported by leading investors in the industry. Atomwise has engineered a cutting-edge machine-learning discovery platform that merges the capabilities of convolutional neural networks with extensive chemical libraries to identify new small-molecule treatments. The key to transforming drug discovery through AI lies in our talented team. We are committed to enhancing our AI platform and leveraging it to revolutionize the discovery of small molecule drugs. It is essential that we confront the most daunting and seemingly insurmountable targets, streamlining the entire drug discovery process to provide developers with increased opportunities for success. Enhanced computational efficiency allows us to screen trillions of compounds virtually, significantly boosting the chances of finding viable solutions. Our impressive model accuracy has successfully addressed the persistent issue of false positives, underscoring the reliability of our approach. Ultimately, our dedication to innovation and excellence sets us apart in the quest for breakthrough therapies.
Description
Nanome serves as an interactive platform designed for collaborative molecular visualization and the exploration of drug discovery. Users can upload protein and small-molecule structures to examine together in a three-dimensional format, accessible through a web browser or various XR headsets such as the Meta Quest 3 and 3S, Apple Vision Pro, and Samsung Galaxy XR. In a shared session, all participants, including a chemist using a headset and a peer working from a laptop, can simultaneously focus on the same molecular feature, no matter their physical locations. The platform incorporates MARA, an AI copilot that efficiently performs docking, co-folding, electrostatics calculations, and ADMET predictions based on straightforward, natural language inputs, utilizing over 300 integrated scientific tools to provide 3D models for further examination. Additionally, Nanome supports a variety of file formats including PDB, mmCIF, SDF, MOL2, PyMOL, and Maestro, while also offering connectivity to platforms like Schrodinger LiveDesign, OpenEye, Cresset Flare, CDD Vault, KNIME, and Jupyter. For enterprises, deployment options include single-tenant or on-premises setups, enhancing security and control. A free web seat is available, along with a 14-day complete trial that requires no credit card for access. Overall, Nanome is revolutionizing how teams collaborate in the field of molecular science.
API Access
Has API
No
API Access
Has API
No
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
$20.83/month/user (academic)
Free Trial
Yes
Free Version
Yes
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
Yes
iPhone App
No
iPad App
No
Android App
No
Windows
Yes
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
No
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
Atomwise
Founded
2012
Country
United States
Website
www.atomwise.com
Vendor Details
Company Name
Nanome
Founded
2015
Country
United States
Website
nanome.ai
Product Features
Product Features
Alternatives
Alternatives
No Alternatives